BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

944 related articles for article (PubMed ID: 29890622)

  • 21. Liquid biopsy for brain tumors.
    Shankar GM; Balaj L; Stott SL; Nahed B; Carter BS
    Expert Rev Mol Diagn; 2017 Oct; 17(10):943-947. PubMed ID: 28875730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges and achievements of liquid biopsy technologies employed in early breast cancer.
    Alba-Bernal A; Lavado-Valenzuela R; Domínguez-Recio ME; Jiménez-Rodriguez B; Queipo-Ortuño MI; Alba E; Comino-Méndez I
    EBioMedicine; 2020 Dec; 62():103100. PubMed ID: 33161226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid biopsies for management of pancreatic cancer.
    Samandari M; Julia MG; Rice A; Chronopoulos A; Del Rio Hernandez AE
    Transl Res; 2018 Nov; 201():98-127. PubMed ID: 30118658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of liquid biopsy in bone and soft tissue sarcomas: Present and future.
    Li X; Seebacher NA; Hornicek FJ; Xiao T; Duan Z
    Cancer Lett; 2018 Dec; 439():66-77. PubMed ID: 30223067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
    Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
    Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy.
    Marrugo-Ramírez J; Mir M; Samitier J
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid biopsy: miRNA as a potential biomarker in oral cancer.
    Mazumder S; Datta S; Ray JG; Chaudhuri K; Chatterjee R
    Cancer Epidemiol; 2019 Feb; 58():137-145. PubMed ID: 30579238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.
    Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy.
    Kong W; Chen T; Li Y
    Methods Mol Biol; 2023; 2695():127-143. PubMed ID: 37450116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating cell-free nucleic acids: characteristics and applications.
    Pös O; Biró O; Szemes T; Nagy B
    Eur J Hum Genet; 2018 Jul; 26(7):937-945. PubMed ID: 29681621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid Biopsy for Investigation of Cancer DNA in Esophageal Squamous Cell Carcinoma.
    Smith RA; Lam AK
    Methods Mol Biol; 2020; 2129():203-215. PubMed ID: 32056180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular screening of head neck cancer.
    Mali SB
    Oral Oncol; 2023 Sep; 144():106481. PubMed ID: 37399708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of various liquid biopsy methods in detecting colorectal cancer: A meta-analysis.
    Zhu Y; Yang T; Wu Q; Yang X; Hao J; Deng X; Yang S; Gu C; Wang Z
    Cancer Med; 2020 Aug; 9(16):5699-5707. PubMed ID: 32628360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer.
    Freitas AJA; Causin RL; Varuzza MB; Calfa S; Hidalgo Filho CMT; Komoto TT; Souza CP; Marques MMC
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid Biopsy: A New Tool in Oncology.
    Costa JL; Schmitt FC
    Acta Cytol; 2019; 63(6):448. PubMed ID: 31266005
    [No Abstract]   [Full Text] [Related]  

  • 37. Liquid biopsy for liver diseases.
    Mann J; Reeves HL; Feldstein AE
    Gut; 2018 Dec; 67(12):2204-2212. PubMed ID: 30177542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis.
    De Rubis G; Rajeev Krishnan S; Bebawy M
    Trends Pharmacol Sci; 2019 Mar; 40(3):172-186. PubMed ID: 30736982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
    Boerrigter E; Groen LN; Van Erp NP; Verhaegh GW; Schalken JA
    Expert Rev Mol Diagn; 2020 Feb; 20(2):219-230. PubMed ID: 31577907
    [No Abstract]   [Full Text] [Related]  

  • 40. Liquid biopsy enters the clinic - implementation issues and future challenges.
    Ignatiadis M; Sledge GW; Jeffrey SS
    Nat Rev Clin Oncol; 2021 May; 18(5):297-312. PubMed ID: 33473219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.